Axsome Therapeutics (AXSM): next trial readout expected around 2028-06-30
$AXSM · Axsome Therapeutics, Inc.Trials that could report in the next 12 months: 2BiopharmaCTG
Catalyst timeline
Dates are estimated from each trial's registered completion date — none are FDA decision dates. Counts trials that fit our shared poll budget, not everything AXSM is running — see methodology.
- 2028-06-30in 97wA Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD
- 2028-06-30in 97wA Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD
Pipeline
| Program | Phase | Status | Primary completion | Trial |
|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of Solriamfetol in Children … | Phase 3 | Recruitingstill enrolling patients | 2028-06-30 | NCT07717879 |
| A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescen… | Phase 3 | Recruitingstill enrolling patients | 2028-06-30 | NCT07717892 |
| Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephri… | Phase 3 | Recruitingstill enrolling patients | NCT06568367 | |
| A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in… | Phase 3 | Enrolling By Invitation | NCT06878976 | |
| Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disor… | Phase 3 | Recruitingstill enrolling patients | NCT06413433 | |
| Clinical Assessment of Response in the Treatment of Depression With Da… | Phase 3 | Recruitingstill enrolling patients | NCT07484217 | |
| Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized W… | Phase 3 | Recruitingstill enrolling patients | NCT07398417 | |
| Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia | Phase 3 | Enrolling By Invitation | NCT07637162 |
+ 1 more tracked trial
| Program | Phase | Status | Primary completion | Trial |
|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of AXS-05 for Smoking Cess… | Phase 3 | Recruitingstill enrolling patients | NCT07766655 |
Status-change history
Every ClinicalTrials.gov change recorded for AXSM's trials — a running history no other tracker shows.
No status changes detected yet for this ticker.
Frequently asked
When is AXSM's next PDUFA date?
No disclosed PDUFA date is currently tracked for this ticker.
What phase is AXSM's lead program in?
Phase 3 — recruiting.
Where does this data come from?
ClinicalTrials.gov v2 API (trial status + diffs) and company 8-K/press-release disclosures (PDUFA dates). Every number links to its source.